2018
DOI: 10.1021/acs.jmedchem.8b00343
|View full text |Cite
|
Sign up to set email alerts
|

Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1

Abstract: Urea transporter A (UT-A) isoforms encoded by the Slc14a2 gene are expressed in kidney tubule epithelial cells, where they facilitate urinary concentration. UT-A1 inhibition is predicted to produce a unique salt-sparing diuretic action in edema and hyponatremia. Here we report the discovery of 1,2,4-triazoloquinoxalines and the analysis of 37 synthesized analogues. The most potent compound, 8ay, containing 1,2,4-triazolo[4,3-a]quinoxaline-substituted benzenesulfonamide linked by an aryl ether, rapidly and reve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 36 publications
(63 reference statements)
0
16
0
Order By: Relevance
“…However, mice showed mild increased urine output and decreased urine osmolality in high vasopressin and fluid-retaining conditions after intraperitoneal administration 26 . Verkman's group 33 reported 1,2,4-triazoloquinoxaline ( Fig. 1 B) as an UT-A1 inhibitor, which significantly increased the urine output and reduced the urine osmolality after intravenous administration in a rat model.…”
Section: Introductionmentioning
confidence: 90%
See 1 more Smart Citation
“…However, mice showed mild increased urine output and decreased urine osmolality in high vasopressin and fluid-retaining conditions after intraperitoneal administration 26 . Verkman's group 33 reported 1,2,4-triazoloquinoxaline ( Fig. 1 B) as an UT-A1 inhibitor, which significantly increased the urine output and reduced the urine osmolality after intravenous administration in a rat model.…”
Section: Introductionmentioning
confidence: 90%
“…In recent decades, several classes of potent small molecule inhibitors of UTs have been identified 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 . Among these inhibitors, the triazolothienopyrimidine inhibitor UTB inh -14 ( Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Small-molecule screening has identified potent and selective inhibitors for various UTs. Additionally, emerging evidence from experiments suggests that UT inhibitors can be developed as a novel class of diuretic drugs (Esteva-Font et al 2015;Yao et al 2012;Zhao et al 2019;Lee et al 2018;Li et al 2014;Li et al 2019). Understanding the mechanism of binding and permeation of urea and urea analogues across UTs might be useful structural determinants which may aid in optimizing the binding of clinically useful UT inhibitors.…”
Section: Amide-aromatic Stacking Interactionsmentioning
confidence: 99%
“…The spectroscopic data were in agreement with those in the literature. 32 5-Chloro-3-(4-(difluoromethoxy)phenyl)- [1,2,4]triazolo [4,3-a]pyrazine (16).…”
Section: 29mentioning
confidence: 99%
“…Compound 11 has been reported to have nanomolar potency as an inhibitor of the kidney urea transporter UT-A1. 16 Compound 12 was recently patented in 2016 as a renal outer medullary potassium channel (ROMK) inhibitor. 17 Sitagliptin (13) was approved by the FDA in 2006 as an antidiabetic drug (dipeptidyl peptidase (DPP)-IV inhibitor).…”
Section: Introductionmentioning
confidence: 99%